Your browser doesn't support javascript.
loading
Commentary on the "Evidence- and Consensus-Based (S3) Guidelines for the Treatment of Actinic Keratosis" Published by the International League of Dermatological Societies in Cooperation with the European Dermatology Forum.
Diepgen, Thomas L; Kresken, Joachim; Krutmann, Jean; Merk, Hans F; Senger, Erik; Surber, Christian; Szeimies, Rolf-Markus.
Affiliation
  • Diepgen TL; Department of Clinical Social Medicine, Occupational and Environmental Dermatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kresken J; Irmgardis Pharmacy, Viersen, Germany.
  • Krutmann J; IUF - Leibniz Institute for Environmental Research, Düsseldorf, Germany.
  • Merk HF; Department of Dermatology and Allergology, University Hospital, Aachen, Germany.
  • Senger E; Dermatology practice, Seligenstadt, Germany.
  • Surber C; Departments of Dermatology Clinics, University Hospitals, Basel, Switzerland.
  • Szeimies RM; Departments of Dermatology Clinics, University Hospitals, Zurich, Switzerland.
Skin Pharmacol Physiol ; 31(3): 144-146, 2018.
Article in En | MEDLINE | ID: mdl-29614495
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Practice Guidelines as Topic / Keratosis, Actinic Type of study: Guideline Limits: Humans Language: En Journal: Skin Pharmacol Physiol Journal subject: DERMATOLOGIA / FARMACOLOGIA / FISIOLOGIA Year: 2018 Document type: Article Affiliation country: Germany Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Practice Guidelines as Topic / Keratosis, Actinic Type of study: Guideline Limits: Humans Language: En Journal: Skin Pharmacol Physiol Journal subject: DERMATOLOGIA / FARMACOLOGIA / FISIOLOGIA Year: 2018 Document type: Article Affiliation country: Germany Country of publication: Switzerland